{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T07:06:21Z","timestamp":1789023981127,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T00:00:00Z","timestamp":1787356800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T00:00:00Z","timestamp":1787356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s00415-026-14079-3","type":"journal-article","created":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T08:51:09Z","timestamp":1787388669000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic performance of the 2023 International MOGAD Panel criteria in broad diagnostic-evaluation and MOG-IgG-positive enriched cohorts: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"273","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-4753-210X","authenticated-orcid":false,"given":"Xiyi","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2179-0731","authenticated-orcid":false,"given":"Wanwei","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8379-9885","authenticated-orcid":false,"given":"Yixin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9884-1111","authenticated-orcid":false,"given":"Lang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1007-023X","authenticated-orcid":false,"given":"Huiru","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,22]]},"reference":[{"key":"14079_CR1","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/S1474-4422(21)00218-0","volume":"20","author":"R Marignier","year":"2021","unstructured":"Marignier R, Hacohen Y, Cobo-Calvo A et al (2021) Myelin-oligodendrocyte glycoprotein antibody-associated disease. Lancet Neurol 20:762\u2013772. https:\/\/doi.org\/10.1016\/S1474-4422(21)00218-0","journal-title":"Lancet Neurol"},{"key":"14079_CR2","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/S1474-4422(22)00431-8","volume":"22","author":"B Banwell","year":"2023","unstructured":"Banwell B, Bennett JL, Marignier R et al (2023) Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria. Lancet Neurol 22:268\u2013282. https:\/\/doi.org\/10.1016\/S1474-4422(22)00431-8","journal-title":"Lancet Neurol"},{"key":"14079_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-018-1144-2","volume":"15","author":"S Jarius","year":"2018","unstructured":"Jarius S, Paul F, Aktas O et al (2018) MOG encephalomyelitis: international recommendations on diagnosis and antibody testing. J Neuroinflammation 15:134. https:\/\/doi.org\/10.1186\/s12974-018-1144-2","journal-title":"J Neuroinflammation"},{"key":"14079_CR4","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1001\/jamaneurol.2021.0912","volume":"78","author":"E Sechi","year":"2021","unstructured":"Sechi E, Buciuc M, Pittock SJ et al (2021) Positive predictive value of myelin oligodendrocyte glycoprotein autoantibody testing. JAMA Neurol 78:741\u2013746. https:\/\/doi.org\/10.1001\/jamaneurol.2021.0912","journal-title":"JAMA Neurol"},{"key":"14079_CR5","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209682","volume":"103","author":"E Fonseca","year":"2024","unstructured":"Fonseca E, Oliv\u00e9-Cirera G, Martinez-Hernandez E et al (2024) Investigating the 2023 MOGAD criteria in children and adults with MOG-antibody positivity within and outside attacks. Neurology 103:e209682. https:\/\/doi.org\/10.1212\/WNL.0000000000209682","journal-title":"Neurology"},{"key":"14079_CR6","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.pediatrneurol.2025.08.010","volume":"172","author":"V Sondhi","year":"2025","unstructured":"Sondhi V, Desai N, Lingappa L et al (2025) Validation and modified application of the 2023 International Expert Consensus Criteria for diagnosing myelin oligodendrocyte glycoprotein antibody-associated disease among children with acquired demyelination in resource-limited regions. Pediatr Neurol 172:138\u2013145. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2025.08.010","journal-title":"Pediatr Neurol"},{"key":"14079_CR7","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200456","volume":"12","author":"S Carta","year":"2025","unstructured":"Carta S, Sechi E, Dinoto A et al (2025) Real-life evaluation of the MOGAD diagnostic criteria: application challenges and discrepancies. Neurol Neuroimmunol Neuroinflamm 12:e200456. https:\/\/doi.org\/10.1212\/NXI.0000000000200456","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"14079_CR8","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1136\/jnnp-2023-333227","volume":"95","author":"AG Filippatou","year":"2024","unstructured":"Filippatou AG, Said Y, Chen H et al (2024) Validation of the International MOGAD Panel proposed criteria: a single-centre US study. J Neurol Neurosurg Psychiatry 95:870\u2013873. https:\/\/doi.org\/10.1136\/jnnp-2023-333227","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"14079_CR9","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200183","volume":"11","author":"M Forcadela","year":"2024","unstructured":"Forcadela M, Rocchi C, San Martin D et al (2024) Timing of MOG-IgG testing is key to 2023 MOGAD diagnostic criteria. Neurol Neuroimmunol Neuroinflamm 11:e200183. https:\/\/doi.org\/10.1212\/NXI.0000000000200183","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"14079_CR10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ejpn.2024.01.006","volume":"49","author":"M Kurd","year":"2023","unstructured":"Kurd M, Pratt LT, Gilboa T et al (2023) Validation of the 2023 International Diagnostic Criteria for MOGAD in a pediatric cohort. Eur J Paediatr Neurol 49:13\u201316. https:\/\/doi.org\/10.1016\/j.ejpn.2024.01.006","journal-title":"Eur J Paediatr Neurol"},{"key":"14079_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2023.105150","volume":"81","author":"M Alaboudi","year":"2024","unstructured":"Alaboudi M, Morgan M, Serra A, Abboud H (2024) Utility of the 2023 International MOGAD Panel proposed criteria in clinical practice: an institutional cohort. Mult Scler Relat Disord 81:105150. https:\/\/doi.org\/10.1016\/j.msard.2023.105150","journal-title":"Mult Scler Relat Disord"},{"key":"14079_CR12","doi-asserted-by":"publisher","first-page":"5102","DOI":"10.1007\/s00415-024-12438-6","volume":"271","author":"A Rechtman","year":"2024","unstructured":"Rechtman A, Friedman-Korn T, Zveik O, Shweiki L, Hoichman G, Vaknin-Dembinsky A (2024) Assessing the applicability of the 2023 International MOGAD Panel criteria in real-world clinical settings. J Neurol 271:5102\u20135108. https:\/\/doi.org\/10.1007\/s00415-024-12438-6","journal-title":"J Neurol"},{"key":"14079_CR13","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209321","volume":"103","author":"JA Varley","year":"2023","unstructured":"Varley JA, Champsas D, Prossor T et al (2023) Validation of the 2023 International Diagnostic Criteria for MOGAD in a selected cohort of adults and children. Neurology 103:e209321. https:\/\/doi.org\/10.1212\/WNL.0000000000209321","journal-title":"Neurology"},{"key":"14079_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-025-03875-9","volume":"23","author":"MT Cai","year":"2023","unstructured":"Cai MT, Hua Y, Lai QL et al (2023) Performance of the 2023 diagnostic criteria for MOGAD: real-world application in a Chinese multicenter cohort of pediatric and adult patients. BMC Med 23:40. https:\/\/doi.org\/10.1186\/s12916-025-03875-9","journal-title":"BMC Med"},{"key":"14079_CR15","doi-asserted-by":"publisher","first-page":"189","DOI":"10.7326\/0003-4819-140-3-200402030-00010","volume":"140","author":"P Whiting","year":"2004","unstructured":"Whiting P, Rutjes AWS, Reitsma JB, Glas AS, Bossuyt PMM, Kleijnen J (2004) Sources of variation and bias in studies of diagnostic accuracy: a systematic review. Ann Intern Med 140:189\u2013202. https:\/\/doi.org\/10.7326\/0003-4819-140-3-200402030-00010","journal-title":"Ann Intern Med"},{"key":"14079_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"14079_CR17","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1001\/jama.2017.19163","volume":"319","author":"MDF McInnes","year":"2018","unstructured":"McInnes MDF, Moher D, Thombs BD et al (2018) preferred reporting items for a systematic review and meta-analysis of diagnostic test accuracy studies: the PRISMA-DTA statement. JAMA 319:388\u2013396. https:\/\/doi.org\/10.1001\/jama.2017.19163","journal-title":"JAMA"},{"key":"14079_CR18","doi-asserted-by":"publisher","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","volume":"155","author":"PF Whiting","year":"2011","unstructured":"Whiting PF, Rutjes AWS, Westwood ME et al (2011) QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155:529\u2013536. https:\/\/doi.org\/10.7326\/0003-4819-155-8-201110180-00009","journal-title":"Ann Intern Med"},{"key":"14079_CR19","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1136\/bmj.39500.677199.AE","volume":"336","author":"HJ Sch\u00fcnemann","year":"2008","unstructured":"Sch\u00fcnemann HJ, Oxman AD, Brozek J et al (2008) Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. BMJ 336:1106\u20131110. https:\/\/doi.org\/10.1136\/bmj.39500.677199.AE","journal-title":"BMJ"},{"key":"14079_CR20","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.jclinepi.2005.02.022","volume":"58","author":"JB Reitsma","year":"2005","unstructured":"Reitsma JB, Glas AS, Rutjes AWS, Scholten RJPM, Bossuyt PM, Zwinderman AH (2005) Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol 58:982\u2013990. https:\/\/doi.org\/10.1016\/j.jclinepi.2005.02.022","journal-title":"J Clin Epidemiol"},{"key":"14079_CR21","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1002\/sim.942","volume":"20","author":"CM Rutter","year":"2001","unstructured":"Rutter CM, Gatsonis CA (2001) A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations. Stat Med 20:2865\u20132884. https:\/\/doi.org\/10.1002\/sim.942","journal-title":"Stat Med"},{"key":"14079_CR22","doi-asserted-by":"publisher","DOI":"10.1111\/ene.16445","volume":"31","author":"E Carnero Contentti","year":"2023","unstructured":"Carnero Contentti E, Pestchanker C, Ciampi E et al (2023) The real-world applicability of the 2023 international myelin oligodendrocyte glycoprotein antibody-associated disease criteria in a Latin American cohort. Eur J Neurol 31:e16445. https:\/\/doi.org\/10.1111\/ene.16445","journal-title":"Eur J Neurol"},{"key":"14079_CR23","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1177\/13524585231198754","volume":"29","author":"KH Kim","year":"2023","unstructured":"Kim KH, Kim SH, Park NY, Hyun JW, Kim HJ (2023) Validation of the International MOGAD Panel proposed criteria. Mult Scler 29:1680\u20131683. https:\/\/doi.org\/10.1177\/13524585231198754","journal-title":"Mult Scler"},{"key":"14079_CR24","doi-asserted-by":"publisher","unstructured":"(2025) ECTRIMS 2025 abstracts free communication and scientific session. Mult Scler 31(Suppl 3):3\u2013135. https:\/\/doi.org\/10.1177\/13524585251358339","DOI":"10.1177\/13524585251358339"},{"issue":"Suppl 1","key":"14079_CR25","doi-asserted-by":"publisher","DOI":"10.1055\/s-0045-1812154","volume":"56","author":"EM Wendel","year":"2025","unstructured":"Wendel EM, Zengin A, Panzer A et al (2025) Diagnostic value of MOGAD criteria in the context of low MOG-IgG antibody titer in children. Neuropediatrics 56(Suppl 1):S17. https:\/\/doi.org\/10.1055\/s-0045-1812154","journal-title":"Neuropediatrics"},{"key":"14079_CR26","doi-asserted-by":"publisher","first-page":"e1250","DOI":"10.1212\/WNL.0000000000007096","volume":"92","author":"PJ Waters","year":"2019","unstructured":"Waters PJ, Komorowski L, Woodhall M et al (2019) A multicenter comparison of MOG-IgG cell-based assays. Neurology 92:e1250\u2013e1255. https:\/\/doi.org\/10.1212\/WNL.0000000000007096","journal-title":"Neurology"},{"key":"14079_CR27","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000674","volume":"7","author":"M Reindl","year":"2020","unstructured":"Reindl M, Schanda K, Woodhall M et al (2020) International multicenter examination of MOG antibody assays. Neurol Neuroimmunol Neuroinflamm 7:e674. https:\/\/doi.org\/10.1212\/NXI.0000000000000674","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"14079_CR28","doi-asserted-by":"publisher","first-page":"3555","DOI":"10.1007\/s00415-020-10024-0","volume":"267","author":"M Gastaldi","year":"2020","unstructured":"Gastaldi M, Scaranzin S, Jarius S et al (2020) Cell-based assays for the detection of MOG antibodies: a comparative study. J Neurol 267:3555\u20133564. https:\/\/doi.org\/10.1007\/s00415-020-10024-0","journal-title":"J Neurol"},{"key":"14079_CR29","doi-asserted-by":"publisher","first-page":"2840","DOI":"10.1007\/s00415-024-12180-z","volume":"271","author":"M Risi","year":"2024","unstructured":"Risi M, Greco G, Masciocchi S et al (2024) MOG-IgG testing strategies in accordance with the 2023 MOGAD criteria: a clinical-laboratory assessment. J Neurol 271:2840\u20132843. https:\/\/doi.org\/10.1007\/s00415-024-12180-z","journal-title":"J Neurol"},{"key":"14079_CR30","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1001\/jamaneurol.2018.1814","volume":"75","author":"AS L\u00f3pez-Chiriboga","year":"2018","unstructured":"L\u00f3pez-Chiriboga AS, Majed M, Fryer J et al (2018) Association of MOG-IgG serostatus with relapse after acute disseminated encephalomyelitis and proposed diagnostic criteria for MOG-IgG-associated disorders. JAMA Neurol 75:1355\u20131363. https:\/\/doi.org\/10.1001\/jamaneurol.2018.1814","journal-title":"JAMA Neurol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-14079-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-026-14079-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-14079-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T06:16:46Z","timestamp":1789021006000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-026-14079-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,22]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["14079"],"URL":"https:\/\/doi.org\/10.1007\/s00415-026-14079-3","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,22]]},"assertion":[{"value":"17 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that there are no competing interests.","order":1,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The manuscript does not contain clinical studies or individual patient data. Ethics approval and informed consent were therefore not required.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"537"}}